vs

Side-by-side financial comparison of HARROW, INC. (HROW) and Ribbon Communications Inc. (RBBN). Click either name above to swap in a different company.

Ribbon Communications Inc. is the larger business by last-quarter revenue ($162.6M vs $89.1M, roughly 1.8× HARROW, INC.). Ribbon Communications Inc. runs the higher net margin — 54.8% vs 7.4%, a 47.3% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs -10.3%). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs -8.1%).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

Ribbon Communications Inc. is a public company that makes software, IP and optical networking solutions for service providers, enterprises and critical infrastructure sectors. The company was formed in 2017, following the merger of Genband and Sonus Networks and is headquartered in Plano, Texas.

HROW vs RBBN — Head-to-Head

Bigger by revenue
RBBN
RBBN
1.8× larger
RBBN
$162.6M
$89.1M
HROW
Growing faster (revenue YoY)
HROW
HROW
+43.6% gap
HROW
33.3%
-10.3%
RBBN
Higher net margin
RBBN
RBBN
47.3% more per $
RBBN
54.8%
7.4%
HROW
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
-8.1%
RBBN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HROW
HROW
RBBN
RBBN
Revenue
$89.1M
$162.6M
Net Profit
$6.6M
$89.1M
Gross Margin
79.3%
42.9%
Operating Margin
17.5%
37.6%
Net Margin
7.4%
54.8%
Revenue YoY
33.3%
-10.3%
Net Profit YoY
-2.2%
EPS (diluted)
$0.20
$0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
RBBN
RBBN
Q1 26
$162.6M
Q4 25
$89.1M
$227.3M
Q3 25
$71.6M
$215.4M
Q2 25
$63.7M
$220.6M
Q1 25
$47.8M
$181.3M
Q4 24
$66.8M
$251.4M
Q3 24
$49.3M
$210.2M
Q2 24
$48.9M
$192.6M
Net Profit
HROW
HROW
RBBN
RBBN
Q1 26
$89.1M
Q4 25
$6.6M
Q3 25
$1.0M
$-12.1M
Q2 25
$5.0M
$-11.1M
Q1 25
$-17.8M
$-26.2M
Q4 24
$6.8M
Q3 24
$-4.2M
$-13.4M
Q2 24
$-6.5M
$-16.8M
Gross Margin
HROW
HROW
RBBN
RBBN
Q1 26
42.9%
Q4 25
79.3%
53.3%
Q3 25
75.3%
50.1%
Q2 25
74.5%
49.6%
Q1 25
67.5%
45.4%
Q4 24
78.8%
55.7%
Q3 24
75.6%
52.1%
Q2 24
74.4%
50.8%
Operating Margin
HROW
HROW
RBBN
RBBN
Q1 26
37.6%
Q4 25
17.5%
4.1%
Q3 25
20.6%
1.3%
Q2 25
17.9%
1.9%
Q1 25
-23.5%
-10.8%
Q4 24
19.3%
13.2%
Q3 24
2.7%
-0.4%
Q2 24
3.1%
-1.0%
Net Margin
HROW
HROW
RBBN
RBBN
Q1 26
54.8%
Q4 25
7.4%
Q3 25
1.4%
-5.6%
Q2 25
7.8%
-5.0%
Q1 25
-37.2%
-14.5%
Q4 24
10.1%
Q3 24
-8.6%
-6.4%
Q2 24
-13.2%
-8.7%
EPS (diluted)
HROW
HROW
RBBN
RBBN
Q1 26
$0.50
Q4 25
$0.20
$0.50
Q3 25
$0.03
$-0.07
Q2 25
$0.13
$-0.06
Q1 25
$-0.50
$-0.15
Q4 24
$0.19
$0.05
Q3 24
$-0.12
$-0.08
Q2 24
$-0.18
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
RBBN
RBBN
Cash + ST InvestmentsLiquidity on hand
$72.9M
$67.6M
Total DebtLower is stronger
$250.0M
Stockholders' EquityBook value
$52.4M
$419.1M
Total Assets
$399.5M
Debt / EquityLower = less leverage
4.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
RBBN
RBBN
Q1 26
$67.6M
Q4 25
$72.9M
$96.4M
Q3 25
$74.3M
$74.8M
Q2 25
$53.0M
$60.5M
Q1 25
$66.7M
$71.2M
Q4 24
$47.2M
$87.8M
Q3 24
$72.6M
$37.2M
Q2 24
$71.0M
$64.6M
Total Debt
HROW
HROW
RBBN
RBBN
Q1 26
Q4 25
$250.0M
$342.1M
Q3 25
$347.2M
$344.3M
Q2 25
$250.6M
$346.5M
Q1 25
$256.9M
$347.4M
Q4 24
$262.7M
$348.3M
Q3 24
$230.7M
$349.1M
Q2 24
$236.3M
$350.0M
Stockholders' Equity
HROW
HROW
RBBN
RBBN
Q1 26
$419.1M
Q4 25
$52.4M
$449.0M
Q3 25
$47.0M
$360.1M
Q2 25
$49.7M
$370.4M
Q1 25
$56.5M
$381.8M
Q4 24
$69.7M
$404.6M
Q3 24
$58.0M
$395.5M
Q2 24
$58.5M
$405.0M
Total Assets
HROW
HROW
RBBN
RBBN
Q1 26
Q4 25
$399.5M
$1.2B
Q3 25
$363.1M
$1.1B
Q2 25
$345.0M
$1.1B
Q1 25
$364.2M
$1.1B
Q4 24
$389.0M
$1.2B
Q3 24
$351.5M
$1.1B
Q2 24
$306.6M
$1.1B
Debt / Equity
HROW
HROW
RBBN
RBBN
Q1 26
Q4 25
4.77×
0.76×
Q3 25
7.39×
0.96×
Q2 25
5.05×
0.94×
Q1 25
4.55×
0.91×
Q4 24
3.77×
0.86×
Q3 24
3.98×
0.88×
Q2 24
4.04×
0.86×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
RBBN
RBBN
Operating Cash FlowLast quarter
$8.4M
Free Cash FlowOCF − Capex
$8.1M
FCF MarginFCF / Revenue
9.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
1.27×
TTM Free Cash FlowTrailing 4 quarters
$43.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
RBBN
RBBN
Q1 26
Q4 25
$8.4M
$29.2M
Q3 25
$16.6M
$26.5M
Q2 25
$-803.0K
$-795.0K
Q1 25
$19.7M
$-3.5M
Q4 24
$-17.8M
$61.8M
Q3 24
$3.0M
$-14.8M
Q2 24
$-2.7M
$-9.8M
Free Cash Flow
HROW
HROW
RBBN
RBBN
Q1 26
Q4 25
$8.1M
$27.3M
Q3 25
$16.4M
$21.0M
Q2 25
$-969.0K
$-6.5M
Q1 25
$19.5M
$-15.7M
Q4 24
$-18.3M
$53.8M
Q3 24
$2.3M
$-23.7M
Q2 24
$-3.1M
$-12.9M
FCF Margin
HROW
HROW
RBBN
RBBN
Q1 26
Q4 25
9.1%
12.0%
Q3 25
22.9%
9.7%
Q2 25
-1.5%
-2.9%
Q1 25
40.8%
-8.7%
Q4 24
-27.4%
21.4%
Q3 24
4.8%
-11.3%
Q2 24
-6.3%
-6.7%
Capex Intensity
HROW
HROW
RBBN
RBBN
Q1 26
Q4 25
0.4%
0.9%
Q3 25
0.3%
2.6%
Q2 25
0.3%
2.6%
Q1 25
0.4%
6.7%
Q4 24
0.8%
3.2%
Q3 24
1.2%
4.2%
Q2 24
0.7%
1.6%
Cash Conversion
HROW
HROW
RBBN
RBBN
Q1 26
Q4 25
1.27×
Q3 25
16.26×
Q2 25
-0.16×
Q1 25
Q4 24
-2.62×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HROW
HROW

Segment breakdown not available.

RBBN
RBBN

Service$94.5M58%
Product$68.1M42%

Related Comparisons